Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs-Reference-Cited by-同舟云学术

Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs

Published:2020-02-03 Issue: Volume:10 Page:
ISSN:1664-2392
Container-title:Frontiers in Endocrinology
language:
Short-container-title:Front. Endocrinol.

Author:

Gadelha Mônica,Bex Marie,Colao Annamaria,Pedroza García Elier Mitsael,Poiana Catalina,Jimenez-Sanchez Marisela,Yener Serkan,Mukherjee Rishav,Bartalotta Amy,Maamari Ricardo,Raverot Gérald

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Reference30 articles.

1. Acromegaly;Colao;Nat Rev Dis Primers.,2019

2. Systemic complications of acromegaly: epidemiology, pathogenesis, and management;Colao;Endocr Rev.,2004

3. Acromegaly pathogenesis and treatment;Melmed;J Clin Invest.,2009

4. Acromegaly: an endocrine society clinical practice guideline;Katznelson;J Clin Endocrinol Metab.,2014

5. Factors influencing mortality in acromegaly;Holdaway;J Clin Endocrinol Metab.,2004

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults;Cochrane Database of Systematic Reviews;2024-02-06

2. Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up;Journal of Endocrinological Investigation;2024-01-20

3. Current role of pasireotide in the treatment of acromegaly;Best Practice & Research Clinical Endocrinology & Metabolism;2024-01

4. Pituitary Gland Therapies;Endocrinology;2023-12-15

5. New Treatments for Acromegaly in Development;The Journal of Clinical Endocrinology & Metabolism;2023-09-27